Page last updated: 2024-09-03

afdx 384 and octylonium

afdx 384 has been researched along with octylonium in 1 studies

Compound Research Comparison

Studies
(afdx 384)
Trials
(afdx 384)
Recent Studies (post-2010)
(afdx 384)
Studies
(octylonium)
Trials
(octylonium)
Recent Studies (post-2010) (octylonium)
7806972434

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Addison, S; Evangelista, S; Greer, S; Hernon, J; Johns, N; Johnson, I; Lewis, M; Lindqvist, S; Mackay, J; Rhodes, M; Sharp, P; Speakman, C; Stebbings, W; Tighe, R; Watson, M; Williams, M1

Other Studies

1 other study(ies) available for afdx 384 and octylonium

ArticleYear
The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts.
    British journal of pharmacology, 2002, Volume: 137, Issue:7

    Topics: Acetylcholine; Animals; Atropine; Calcium; Calcium Signaling; CHO Cells; Colon; Cricetinae; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Muscarinic Antagonists; Parasympatholytics; Piperidines; Pirenzepine; Quaternary Ammonium Compounds; Receptor, Muscarinic M3; Receptors, Muscarinic; Time Factors; Vasodilator Agents

2002